Related Experiment Video
Updated: May 17, 2026
09:52
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Nanoparticles for Uveal Melanoma Treatment
Sheng Zhang1, Jun Zhou, Zhibing Hu
1Department of Bioengineering, University of Texas at Arlington.
Proceedings of the ... IEEE Conference on Nanotechnology. IEEE Conference on Nanotechnology
|October 23, 2012
Summary
Researchers explored hydrogel particles for targeted chemotherapy delivery in uveal melanoma. Nanoparticles between 100-300 nm showed higher accumulation in ocular tissues, suggesting potential for sustained drug release.
Area of Science:
- Ophthalmology
- Nanotechnology
- Oncology
Background:
- Chemotherapy is a standard treatment for uveal melanoma.
- Frequent intraocular injections are required due to rapid drug clearance from the vitreous.
- Novel drug delivery systems are needed to improve treatment efficacy.
Purpose of the Study:
- To investigate the potential of hydrogel nanoparticles for targeted chemotherapy delivery to uveal melanoma.
- To determine the optimal particle size for accumulation in ocular tissues.
- To evaluate the feasibility of using decorated nanoparticles for sustained drug release.
Main Methods:
- Fluorescent dye-labeled nano- and micro-particles were synthesized.
- Particles were administered intravenously in an animal model.
- Uveal tissue accumulation of particles was quantified using fluorescence imaging.
- Particle distribution and accumulation were analyzed based on size.
Main Results:
- Nanoparticles demonstrated significantly higher accumulation in uveal tissue compared to microparticles.
- The optimal particle size range for uveal tissue accumulation was identified as 100-300 nm.
- Hydrogel particles show promise for localized drug delivery.
Conclusions:
- Hydrogel nanoparticles, particularly in the 100-300 nm range, are effective for targeted delivery to uveal melanoma.
- These nanoparticles can be functionalized for enhanced targeting and sustained chemotherapeutic drug release.
- This approach may reduce the need for frequent intraocular injections, improving uveal melanoma treatment.
